ITW Sebastian Brunemeier - Biologist Expert in Geroscience, Serial Biotech Entrepreneur and VC Investor in Longevity Startups
In this new episode of e², we have the pleasure to discuss with Sebastian Brunemeier, a brilliant and inspiring personality who has dedicated his life to extending the longevity of mankind.
He is a biologist by training, an expert in geroscience (the science of ageing/longevity) and an expert in bio-business. Sebastian is a serial biotech entrepreneur and investor in the longevity field.
Key points in Sebastian’s bio:
Sebastian Brunemeier is the CEO of ImmuneAGE, a co-founder of Cambrian Biopharma and former Principal at Apollo Health Ventures. He was also founder of Samsara Therapeutics, Cyclone Therapeutics, and advisor to several other biotech companies.
Sebastian was a Fulbright Fellow in the biology of aging at the Gulbenkian Institute, awarded the Skaggs-Oxford fellowship at the Scripps Research Institute, and a SENS Foundation Scholar at the Buck Institute for Research on Aging. He was in the DPhil (PhD) program at Oxford as a Clarendon Scholar focusing on the biochemistry of aging, and completed a dual MSc in Life Science Business Management and Molecular Neuroscience from the University of Amsterdam as an Amsterdam Excellence Scholar.
Healthspan Capital is a seed fund supporting longevity and geroscience companies developing therapies that extend a healthy lifespan.
Founder-CEO at ImmuneAGE Pharma
Drug discovery platform for immune system rejuvenation.
Founder-COO at Samsara Therapeutics a biopharmaceutical platform company aiming to discover first-in-class therapeutics that extend healthy lifespans. Samsara's platform is the largest-ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that extend a healthy lifespan and enhance autophagy.
Co-Founder CIO at Cambrian Biopharma
Cambrian Biopharma is a biotech venture capital holding company that helps scientists transmit their discoveries from the lab into the clinic. Cambrian has raised ±$160M since its founding, with >15 subsidiaries. Cambrian is uniquely focused on a specific field of biomedical research: the biology of ageing, also known as geroscience. Cambrian is built on an emerging business model that we call a ‘Distributed R&D Company’ or ‘DisCo’ that blends the best aspects of the venture capital firm with the capital-efficient, agile domain expertise of a mid-sized biotech company.
Co-Founder CEO at Cyclone Therapeutics
Cyclone Therapeutics is a preclinical-stage drug discovery company spun out of The Scripps Research Institute. The company is focused on enhancing protein quality control by modulating translation, based on an anti-inflammatory 'integrated stress response mimetic' MoA.
Advisor at Molecule
Molecule is a decentralized token exchange and licensing platform for biotech intellectual property. Originators of the VitaDAO decentralized financing platform for longevity biotech. Molecule aims to enable the funding of Academic research in ageing/longevity and other important health issues. For this, Molecule offers to tokenize the Academic IPs into IP-NFTs.
In this new episode, discover the inspiring journey of Sebastian Brunemeier from science to entrepreneurship and investment. Discover his Why, the driving force that nurtures Sebastian to make us live longer and healthier.
Co-Host of this episode: Harold Knoll is a Sci-Tech curious and futurist, founder CEO of DAYU a longevity startup that ambitions to tokenize our genes!
PhD students & Post-docs in life science who would like to learn more about biotech entrepreneurship, Sebastian has a great list of key books. Contact him on Linkedin introduce yourself and request his list.
BONUS: Sebastian's ITWs & Conferences
E² - Epistémê Entrepreneur